2018Chin J Colorec Dis (Electronic Edition)Requires access

Take a second thought about lateral pelvic lymph node dissection of rectal cancer

Fanghai Han

Open publisher page 0 citations

Abstract

D. Gerota first put forward a research about rectal lymphatic flow in 1895, which the lymph flow can be divided into three directions: the upper, middle and lower directions. After correction by the further study of other scholars, now it is generally believed that the lateral lymph flow can be divided into four directions: 1. The front direction, running from the bladder artery, prostate arteries, obturator artery to common iliac artery; 2. Running from middle rectal artery to internal iliac artery; 3. Along the middle sacral artery and the lateral sacral artery to the abdominal aortic bifurcation area; 4. Running from inferior rectal artery to internal iliac artery. Lateral lymph node metastasis occurs mainly in low rectal cancer, which tumor infiltration depth is deeper than the muscular layer. Lateral lymph nodes were not included in the range of TME radical operation for rectal cancer. NCCN guidelines for rectal cancer did not mention concept of lateral lymph nodes, while the Japanese Colorectal Cancer Classification (JCCC) held that lateral lymph nodes dissection should be performed in low rectal cancer if there were indications. Western scholars think that lateral lymph node metastasis is a disease, and lateral lymph node dissection is hard to improve long-term clinical outcome. Japanese scholars insist that lateral lymph node metastasis is local disease, and TME + lateral lymph node dissection was standard operation for low rectal cancer. Western scholars think that preoperative chemoradiotherapy can take the place of lateral lymph node dissection, while eastern scholars argue that lateral lymph node dissection is an alternative treatment options for the patients who is not sensitive for preoperative chemoradiotherapy. Whether prophylactic pelvic lateral lymph node dissection should be performed in patients with low rectal cancer remains controversial, however, therapeutic lateral lymph node dissection is standard therapy of rectal cancer in Japanese. Many studies reported an initial exploration about laparoscopic lateral lymph node dissection and showed that it is safe and effective, but multi-center randomized controlled trial are needed to confirm its long-term oncologic outcome. Key words: Rectal neoplasms; Pelvic floor; Lateral pelvic lymph node dissection

About this research paper

What this paper is about

D. Gerota first put forward a research about rectal lymphatic flow in 1895, which the lymph flow can be divided into three directions: the upper, middle and lower directions. After correction by the further study of other scholars, now it is generally believed that the lateral lymph flow can be divided into four directions: 1. The front direction, running from the bladder artery, prostate arteries, obturator artery to common iliac artery; 2. Running from middle rectal artery to internal iliac artery; 3. Along the middle sacral artery and the lateral sacral artery to the abdominal aortic bifurcation area; 4. Running from inferior rectal artery to internal iliac artery. Lateral lymph node metastasis occurs mainly in low rectal cancer, which tumor infiltration depth is deeper than the muscular layer. Lateral lymph nodes were not included in the range of TME radical operation for rectal cancer. NCCN guidelines for rectal cancer did not mention concept of lateral lymph nodes, while the Japanese Colorectal Cancer Classification (JCCC) held that lateral lymph nodes dissection should be performed in low rectal cancer if there were indications. Western scholars think that lateral lymph node metastasis is a disease, and lateral lymph node dissection is hard to improve long-term clinical outcome. Japanese scholars insist that lateral lymph node metastasis is local disease, and TME + lateral lymph node dissection was standard operation for low rectal cancer. Western scholars think that preoperative chemoradiotherapy can take the place of lateral lymph node dissection, while eastern scholars argue that lateral lymph node dissection is an alternative treatment options for the patients who is not sensitive for preoperative chemoradiotherapy. Whether prophylactic pelvic lateral lymph node dissection should be performed in patients with low rectal cancer remains controversial, however, therapeutic lateral lymph node dissection is standard therapy of rectal cancer in Japanese. Many studies reported an initial exploration about laparoscopic lateral lymph node dissection and showed that it is safe and effective, but multi-center randomized controlled trial are needed to confirm its long-term oncologic outcome. Key words: Rectal neoplasms; Pelvic floor; Lateral pelvic lymph node dissection

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

D. Gerota first put forward a research about rectal lymphatic flow in 1895, which the lymph flow can be divided into three directions: the upper, middle and lower directions. After correction by the further study of other scholars, now it is generally believed that the lateral lymph flow can be divided into four directions: 1. The front direction, running from the bladder artery, prostate arteries, obturator artery to common iliac artery; 2. Running from middle rectal artery to internal iliac artery; 3. Along the middle sacral artery and the lateral sacral artery to the abdominal aortic bifurcation area; 4. Running from inferior rectal artery to internal iliac artery. Lateral lymph node metastasis occurs mainly in low rectal cancer, which tumor infiltration depth is deeper than the muscular layer. Lateral lymph nodes were not included in the range of TME radical operation for rectal cancer. NCCN guidelines for rectal cancer did not mention concept of lateral lymph nodes, while the Japanese Colorectal Cancer Classification (JCCC) held that lateral lymph nodes dissection should be performed in low rectal cancer if there were indications. Western scholars think that lateral lymph node metastasis is a disease, and lateral lymph node dissection is hard to improve long-term clinical outcome. Japanese scholars insist that lateral lymph node metastasis is local disease, and TME + lateral lymph node dissection was standard operation for low rectal cancer. Western scholars think that preoperative chemoradiotherapy can take the place of lateral lymph node dissection, while eastern scholars argue that lateral lymph node dissection is an alternative treatment options for the patients who is not sensitive for preoperative chemoradiotherapy. Whether prophylactic pelvic lateral lymph node dissection should be performed in patients with low rectal cancer remains controversial, however, therapeutic lateral lymph node dissection is standard therapy of rectal cancer in Japanese. Many studies reported an initial exploration about laparoscopic lateral lymph node dissection and showed that it is safe and effective, but multi-center randomized controlled trial are needed to confirm its long-term oncologic outcome. Key words: Rectal neoplasms; Pelvic floor; Lateral pelvic lymph node dissection

Key concepts: Medicine, Dissection (medical), Lymph node, Inferior mesenteric artery, Colorectal cancer, Lymph, External iliac artery, Internal iliac artery

Related papers

Back to paper searchBrowse research topicsOriginal source
Take a second thought about lateral pelvic lymph node dissection of rectal cancer — Research Paper | ScholarLens